• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL, INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL, INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 71019
Medical Device Problem Code Intermittent Communication Failure (4038)
Health Effect - Clinical Code Inadequate Pain Relief (2388)
Date of Event 09/25/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Patient was implanted with a nalu peripheral nerve stimulator system on (b)(6) 2024 to treat upper back pain.The implantable pulse generator (ipg) was placed in the lower back area with the leads targeting the intercostal nerve.Beginning mid-year 2025 the patient began to report inconsistent connectivity between the ipg and the external therapy discs.Troubleshooting in the field was unable to resolve the issue and concluded that the ipg had migrated within the pocket to no longer be parallel to the skin surface.The position of the ipg was determined to be affecting communication between devices.The patient requested to transition from the nalu device with external wearables to a fully implanted device from a different manufacturer.On (b)(6) 2025 the nalu system was removed and a neurostimulation device from a different manufacturer was implanted.The procedure is reported to have gone smoothly and the new system was covering the areas of pain.
 
Additional Manufacturer Narrative
The nalu system was tested on the day it was implanted to assure appropriate depth of the ipg and all testing returned good results.There are no known events leading up to the changes in connectivity that would be likely to have caused the ipg to migrate.Migration is a known inherent risk of implantable neuromodulation systems.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Common Device Name
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
chelsea gutierrez
2320 faraday ave
suite 100
carlsbad, CA 92008-7241
7144010608
MDR Report Key23398373
Report Number3015425075-2025-00309
Device Sequence Number18686988
Product Code GZF
UDI-Device Identifier00812537037196
UDI-Public(01)00812537037196(11)240801(17)270801
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K183579
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 10/22/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model Number71019
Device Catalogue Number71019
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/25/2025
Initial Report FDA Received Date10/27/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-